Avantax Planning Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,247
Closed -$359K 376
2021
Q4
$359K Hold
8,247
0.01% 251
2021
Q3
$258K Sell
8,247
-180
-2% -$7.08K 0.01% 281
2021
Q2
$357K Hold
8,427
0.02% 236
2021
Q1
$317K Hold
8,427
0.02% 234
2020
Q4
$228K Sell
8,427
-10,662
-56% -$274K 0.01% 259
2020
Q3
$479K Buy
19,089
+190
+1% +$2.77K 0.03% 184
2020
Q2
$144K Sell
18,899
-1,769
-9% -$12.9K 0.01% 271
2020
Q1
$189K Buy
+20,668
New +$125K 0.01% 258

Other funds holding ACH

Avantax Planning Partners's ACH Position: Q1 2022 in Review

Avantax Planning Partners sold out of Accendra Health (ACH) in Q1 2022, closing a stake of 8,247 shares — an estimated $359K sold.

Avantax Planning Partners first reported a position in ACH in Q1 2020 and held it in 8 quarters. The position peaked at $479K in Q3 2020. 266 funds tracked by Wall St. Rank hold ACH as of Q1 2022.

  • Avantax Planning Partners reported no remaining Accendra Health position as of Q1 2022 after selling out during the quarter.
  • Avantax Planning Partners sold 8,247 Accendra Health shares in Q1 2022, an estimated $359K.
  • Avantax Planning Partners first reported a position in Accendra Health in Q1 2020 and held it in 8 quarters.
  • Avantax Planning Partners's Accendra Health position peaked at $479K in Q3 2020.
  • 266 funds tracked by Wall St. Rank held Accendra Health as of Q1 2022.

Based on Avantax Planning Partners's 13F filing for Q1 2022, filed 9 May 2022.